← Home India · nd-india

US FDA approves Viatris's Ryzumvi for the treatment of presbyopia

Source: pharmabiz · 2026-10-19T05:00:00 UTC

Viatris Inc., a global healthcare company, announced that the US Food and Drug Administration (FDA) has approved Ryzumvi (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia in adults.

Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.

Read full story on publisher site →

Related in India

The Big AI Terms Everyone Is Getting Wrong: Open Source, Open Weight And Proprietary

Bernard Marr

Bajaj Finance Q2 Results: Net profit jumps 29% YoY to Rs 6,367 crore, NII up 24%

The Economic Times

Anti-Inflammatory Effects of GLP-1 Medications in Psoriasis and Obesity

Dermatology Times

Buildings ablaze, petrol bombs hurled at parliament: 10 visuals show chaos of Albania protests

The Times of India

Tiny Planet-Forming Disks Reveal Hidden Rings and Gaps

Tech Explorist

Reliance Digital Offers iPhone 17 Pro At Rs 56,990: Exchange Benefits And Conditions Explained

NDTV Profit